Literature DB >> 15526143

Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics.

S Anttila1, A Illi, O Kampman, K M Mattila, T Lehtimäki, E Leinonen.   

Abstract

Several studies have connected brain-derived neurotrophic factor (BDNF) with treatment response to neuroleptics. In recent studies, the BDNF expression was reduced by typical neuroleptics. We conducted a retrospective study on 94 patients with schizophrenia and 98 controls. The BDNF G196A and C270T polymorphisms are not associated with treatment response to typical neuroleptics or with age at first hospitalization. Moreover, these polymorphisms of the BDNF gene are not associated with the risk of schizophrenia.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15526143     DOI： 10.1007/s00702-004-0233-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  14 in total

Review 1.  Imaging genomics and response to treatment with antipsychotics in schizophrenia.

Authors:  Giuseppe Blasi; Alessandro Bertolino
Journal:  NeuroRx       Date:  2006-01

Review 2.  The promise and reality of pharmacogenetics in psychiatry.

Authors:  Peter P Zandi; Jennifer T Judy
Journal:  Psychiatr Clin North Am       Date:  2010-03

3.  Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies.

Authors:  Majid Kheirollahi; Elahe Kazemi; Saeideh Ashouri
Journal:  Cell Mol Neurobiol       Date:  2015-07-02       Impact factor: 5.046

4.  Brain derived neurotropic factor in first-episode psychosis.

Authors:  Peter F Buckley; Anilkumar Pillai; Denise Evans; Edna Stirewalt; Sahebarao Mahadik
Journal:  Schizophr Res       Date:  2007-02-15       Impact factor: 4.939

5.  Pharmacogenetics of Antipsychotic Treatment in Schizophrenia.

Authors:  Samar S M Elsheikh; Daniel J Müller; Jennie G Pouget
Journal:  Methods Mol Biol       Date:  2022

6.  Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study.

Authors:  Mingqing Xu; Sheng Li; Qinghe Xing; Rui Gao; Guoyin Feng; Zhiguang Lin; David St Clair; Lin He
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

7.  Association of the brain-derived neurotrophic factor gene G196A rs6265 polymorphisms and the cognitive function and clinical symptoms of schizophrenia.

Authors:  Jinguo Zhai; Qing Yu; Min Chen; Yan Gao; Qiumei Zhang; Jun Li; Keqin Wang; Feng Ji; Zhonghua Su; Wu Li; Xuemei Li; Juyao Qiao
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

8.  Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.

Authors:  Matea Nikolac Perkovic; Gordana Nedic Erjavec; Maja Zivkovic; Marina Sagud; Suzana Uzun; Alma Mihaljevic-Peles; Oliver Kozumplik; Dorotea Muck-Seler; Nela Pivac
Journal:  Psychopharmacology (Berl)       Date:  2014-03-05       Impact factor: 4.530

9.  BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory.

Authors:  R Nieto; M Kukuljan; H Silva
Journal:  Front Psychiatry       Date:  2013-06-17       Impact factor: 4.157

Review 10.  Brain-derived neurotrophic factor and schizophrenia.

Authors:  Pasquale Di Carlo; Giovanna Punzi; Gianluca Ursini
Journal:  Psychiatr Genet       Date:  2019-10       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.